ASX - Delayed Quote AUD

CurveBeam AI Limited (CVB.AX)

0.1650 -0.0100 (-5.71%)
At close: April 26 at 11:39 AM GMT+10
Key Events
Loading Chart for CVB.AX
DELL
  • Previous Close 0.1750
  • Open 0.1750
  • Bid 0.1700 x --
  • Ask 0.1750 x --
  • Day's Range 0.1650 - 0.1700
  • 52 Week Range 0.1600 - 0.5450
  • Volume 45,981
  • Avg. Volume 58,687
  • Market Cap (intraday) 52.823M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.9100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 0.50

CurveBeam AI Limited provides medical imaging platforms and clinical assessment solutions that focus on the orthopedic market and general bone health screening and diagnostics. It builds artificial intelligence tools to aid in bone separation and segmentation, empowering orthopedic surgeons to make 3D-based deformity measurements to inform clinical decisions. Its AI's Deep Learning AI based platform aids in bone microstructure analysis. The company's target customers include orthopedic practices, imaging centers, and hospitals. CurveBeam AI Limited was founded in 2009 and is headquartered in Hatfield, Pennsylvania.

curvebeamai.com

--

Full Time Employees

June 30

Fiscal Year Ends

Related News

Performance Overview: CVB.AX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CVB.AX
60.24%
S&P/ASX 200 [XJO]
0.20%

1-Year Return

CVB.AX
--
S&P/ASX 200 [XJO]
5.98%

3-Year Return

CVB.AX
--
S&P/ASX 200 [XJO]
5.98%

5-Year Return

CVB.AX
--
S&P/ASX 200 [XJO]
5.98%

Compare To: CVB.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CVB.AX

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    52.82M

  • Enterprise Value

    52.39M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.19

  • Price/Book (mrq)

    1.13

  • Enterprise Value/Revenue

    6.50

  • Enterprise Value/EBITDA

    -1.20

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -21.62%

  • Return on Equity (ttm)

    -286.73%

  • Revenue (ttm)

    9.4M

  • Net Income Avi to Common (ttm)

    -56.73M

  • Diluted EPS (ttm)

    -0.9100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    14.96M

  • Total Debt/Equity (mrq)

    30.96%

  • Levered Free Cash Flow (ttm)

    -27.13M

Research Analysis: CVB.AX

Analyst Price Targets

0.50
0.50 Average
0.1650 Current
0.50 High
 

Fair Value

 

Company Insights: CVB.AX

People Also Watch